Follow Us: Follow Prostate on Facebook Follow ProstateNet on Twitter Get the Prostate.net RSS feed

Monthly Archives: February 2012

Erectile Dysfunction Supplement RegenErect Recalled

by James Craig on February 29 Leave the first comment

The Food and Drug Administration has announced that the makers of the erectile dysfunction supplement RegenErect have voluntarily recalled its product because it contains tadalafil, also known as Cialis. Tadalafil is an FDA-approved drug for the treatment of erectile dysfunction. Regeneca Inc. confirmed their product contains tadalafil after an independent lab analysis was conducted. The… Continue Reading »


More about:

New Study-Side Effects of Proton Therapy

by Editor on February 18 Leave the first comment

An expensive, cutting-edge prostate cancer therapy promoted by the University of Texas M.D. Anderson Cancer Center is being questioned for increasing the very problem it claims to reduce – side effects. In a new study, records of select patients with prostate cancer show that those treated with  proton therapy had more bowel complications, such as bleeding, than those… Continue Reading »


More about:

Curcumin/Turmeric Slows Growth of Prostate Cancer Tumors

by Editor on February 10 Leave the first comment

The latest hot news about curcumin, the active ingredient in the curry spice turmeric, is that it may slow the growth of prostate cancer tumors. The results of the pre-clinical study suggest curcumin may be helpful in men with castration-resistant prostate cancer who were taking hormone therapy (androgen deprivation therapy [ADT). A research team at… Continue Reading »


More about:

Is Heart Disease a Risk Factor for Prostate Cancer?

by Editor on February 9 Leave the first comment

Findings of an analysis conducted by researchers at the Duke Cancer Institute Results raise an interesting question—is heart disease a risk factor for prostate cancer? The possibility arose after evaluation of data from 6,390 men enrolled in a four-year trial that tested the impact of the drug dutasteride in reducing the risk of prostate cancer…. Continue Reading »


More about:

Severe Sleep Problems May Increase Prostate Cancer Risk

by Editor on February 4 Leave the first comment

Older men who experience severe sleep problems may be at greater risk of prostate cancer, according to a study presented at the Genitourinary Cancers Symposium in San Francisco. Since this was an observational study, the researchers did not explore whether treating sleep problems would help reduce the risk of prostate cancer. In this new study,… Continue Reading »


More about:

Alpharadin Benefits in Hormone Resistant Prostate Cancer

by James Craig on February 2 Leave the first comment

A novel injectable drug called radium-223 chloride (Alpharadin) improved survival by 30% in men with hormone therapy resistant prostate cancer in a recent clinical trial. Alpharadin also significantly reduced the men’s risk of bone fracture and spinal cord compression, as well as the need for external beam radiation. These trial results were reported at a… Continue Reading »


More about:

Vigorous Exercise Lowers Risk of Prostate Cancer Progression

by Editor on February 1 Leave the first comment

Scientists at the University of California, San Francisco (UCSF) believe they have discovered why vigorous exercise lowers the risk of prostate cancer progression. While previous studies have indicated that vigorous exercise is associated with a lower risk of prostate cancer progression, they did not identify why this benefit occurred. Now, a research team has identified… Continue Reading »


More about:

Study Questions Proton Therapy for Prostate Cancer

by Editor on February 1 Leave the first comment

A warning to men considering a pricey new treatment for prostate cancer called proton therapy: Research suggests it might have more side effects than traditional radiation does. A study of Medicare records found that men treated with proton beams later had one-third more bowel problems, such as bleeding and blockages, than similar men given conventional… Continue Reading »


More about:

  • ADVERTISEMENT



  • ADVERTISEMENT